Does DUPILUMAB Cause Injection site indentation? 51 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Injection site indentation have been filed in association with DUPILUMAB (Dupixent). This represents 0.0% of all adverse event reports for DUPILUMAB.
51
Reports of Injection site indentation with DUPILUMAB
0.0%
of all DUPILUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Injection site indentation From DUPILUMAB?
Of the 51 reports, 2 (3.9%) required hospitalization.
Is Injection site indentation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Injection site indentation?
ADALIMUMAB (241)
EXENATIDE (224)
EVOLOCUMAB (189)
ERENUMAB-AOOE (152)
GLATIRAMER (149)
ALIROCUMAB (73)
SEMAGLUTIDE (66)
TIRZEPATIDE (55)
INTERFERON BETA-1A (46)
DULAGLUTIDE (39)
Which DUPILUMAB Alternatives Have Lower Injection site indentation Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE